Arterium Corporation’s new experiments are aimed at designing medicines for use in emergency and military situations. It is still not clear when these medicines will hit the market shelves since it usually takes three to four years for a medicine to move from the designing stage to final circulation in the market.

Arterium’s public relation service told the Interfax-Ukraine news agency that the last drug registered by the company was Tramix hemostatic, in December 2014. Around 9,000 packages of the drug have been shipped so far.

"Ukrainian medicines are able to satisfy the needs in drugs used in the conflict zone,” states Arterium Corporation, which includes the Kyivmedpreparat manufacturer of antibiotics and Galychpharm, a leader in the production of plant-based drugs.

The corporation currently has a product portfolio of 148 drugs, including modern antibiotics of all key groups and generations and artificial plasma extenders.

There have been major advances in medical and wound care across the world over the last century. These include X-rays and antibiotics, with much progress made in military health care especially during the Iraq and Afghanistan wars, reports News Radio 1200 WOAI.

Vice Admiral Michael Cowan (ret.), former Surgeon General of the US Navy, told News Radio 1200 WOAI that many of the advances in the 21st century have focused on prosthetic care, due to the nature of the weapons used by the enemies.

Admiral Cowan further says that major developments are in the pipeline which will make that recovery better for the patients, including advancements in 'smart' prosthetics. The advancement has led to medical breakthroughs such as electronification of limbs.

Contact the writer at feedback@ibtimes.com.au or tell us what you think below.

RELATED STORIES